NCT03925519

Brief Summary

  • Physical exercise for 6 months produced significant improvement in adiponectin, hs-CRP, and nitric oxide (NO) and was significantly correlated with adiposity markers, lipid profile and glycemic control factors in both obese and non-obese diabetic patients.
  • Patients with good physical activity reported a significant decrease in BMI, CHD risk scores, reduced hs-CRP, an increase in the levels of adiponectin and nitric oxide.
  • In patients with type 2 diabetes mellitus, adiposity markers, lipid profile, hs-CRP, and adiponectin were significantly improved following moderate exercise interventions

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 25, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 26, 2014

Completed
4.9 years until next milestone

First Submitted

Initial submission to the registry

April 17, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 24, 2019

Completed
Last Updated

April 24, 2019

Status Verified

April 1, 2019

Enrollment Period

1.2 years

First QC Date

April 17, 2019

Last Update Submit

April 22, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Estimation of coronary heart disease risk score

    The incidence risk score of coronary heart disease among type 2 diabetic participants .patients were classified into T2DM patients with high CHD risk (UKPDS risk ; ≥ 20%), moderate CHD risk (UKPDS risk ; 10-20%), and low (UKPDS risk;\< 10%) .

    six months

  • Analysis of blood sugar, glycated hemoglobin (HbA1c)

    Blood glucose was measured using a glucose oxidase and peroxidase (GOD-POD) colorimetric method before and after exercise training

    six months

Secondary Outcomes (1)

  • Analysis of Nitric Oxide

    six months

Study Arms (2)

non-obese

non-obese diabetic patients (n= 25, BMI ≤ 30 kg/m2) were subjected to supervised aerobic exercise

obese group

obese diabetic group (n= 25, BMI ≥ 30 kg/m2)

Other: Supervised aerobic exercise

Interventions

Eligibility Criteria

Age45 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Fifty subjects diagnosed with type 2 diabetes for more than 5 years aged 45-70 years were invited in the period from 2013 to 2014 to participate in this study. Patients were diagnosed according to the criteria of American diabetes association.32 Based on the values of BMI, the patients were classified into two groups, obese diabetic group (n= 25, BMI ≥ 30 kg/m2) and non-obese group (n= 25, BMI ≤ 30 kg/m2).

You may qualify if:

  • patients with type 2 diabetes for more than 5 years.
  • Patients who were diagnosed according to the criteria of the American diabetes association.
  • Not receiving any drugs affecting the data obtained
  • had Normal daily diets
  • Not participating in any other exercise programs
  • Without any musculoskeletal disorders affecting an exercise program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples were obtained from all subjects at 0800 h after an overnight fast before and after the training program Venous blood samples (5 mL) were collected into plain tubes, the samples were allowed to clot for half an hour following which samples were centrifuged for 15 minutes at 2000 rpm. Samples were given a coded study identification number and were stored frozen at 80°C until analysis.

MeSH Terms

Conditions

Diabetes MellitusMotor Activity

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical Professor

Study Record Dates

First Submitted

April 17, 2019

First Posted

April 24, 2019

Study Start

January 25, 2013

Primary Completion

April 15, 2014

Study Completion

May 26, 2014

Last Updated

April 24, 2019

Record last verified: 2019-04